Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist

被引：41
|
作者：
Lambert, D. G. [1 ]
Bird, M. F. [1 ]
Rowbotham, D. J. [1 ]
机构：
[1] Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Div Anaesthesia Crit Care & Pain Management, Leicester LE2 7LX, Leics, England
来源：
BRITISH JOURNAL OF ANAESTHESIA | 2015年 / 114卷 / 03期
关键词：
KNOCK-OUT MICE; MORPHINE-TOLERANCE; DRUG-ABUSE; DEPENDENCE; NOP; PEPTIDE; TARGET;
D O I：
10.1093/bja/aeu332
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：364 / 366
页数：3
相关论文
共 50 条
  • [21] UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor
    Calo, G
    Guerrini, R
    Rizzi, A
    Salvadori, S
    Burmeister, M
    Kapusta, DR
    Lambert, DG
    Regoli, D
    CNS DRUG REVIEWS, 2005, 11 (02): : 97 - 112
  • [22] Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys
    Rizzi, A.
    Sukhtankar, D. D.
    Ding, H.
    Hayashida, K.
    Ruzza, C.
    Guerrini, R.
    Calo, G.
    Ko, M. C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (14) : 3661 - 3670
  • [23] Behavioral and Neurochemical Effects of Nociceptin/Orphanin FQ Receptor Activation in the Social Defeat Protocol
    Camara, Alice Barros
    Brandao, Igor Augusto
    BEHAVIORAL NEUROSCIENCE, 2023, 137 (01) : 52 - 66
  • [24] The Functional Antiopioid Action of the Ventrolateral Periaqueductal Gray Nociceptin/Orphanin FQ and Nociceptin Receptor System Underlies DAMGO Analgesic Tolerance
    Parenti, Carmela
    Scoto, Giovanna M.
    PHARMACOLOGY, 2010, 86 (03) : 138 - 144
  • [25] Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24
    Fischetti, Carmela
    Camarda, Valeria
    Rizzi, Anna
    Pela, Michela
    Trapella, Claudio
    Guerrini, Remo
    McDonald, John
    Lambert, David G.
    Salvadori, Severo
    Regoli, Domenico
    Calo, Girolamo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 614 (1-3) : 50 - 57
  • [26] Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands
    Corrado, Sandra
    Battisti, Umberto M.
    Sorbi, Claudia
    Tait, Annalisa
    Malfacini, Davide
    Camarda, Valeria
    Calo, Girolamo
    Brasili, Livio
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (04) : 447 - 458
  • [27] Nociceptin/Orphanin FQ Opioid Peptide-Receptor Expression in the Endometriosis-Associated Nerve Fibers-Possible Treatment Option?
    Guan, Qihui
    Velho, Renata Voltolini
    Jordan, Alice
    Pommer, Sabrina
    Radde, Irene
    Sehouli, Jalid
    Mechsner, Sylvia
    CELLS, 2023, 12 (10)
  • [28] The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101 Reduces Microvascular Inflammation to Lipopolysaccharide In Vivo
    Brookes, Zoe L. S.
    Stedman, Emily N.
    Brown, Nicola J.
    Hebbes, Christopher P.
    Guerrini, Remo
    Calo, Girolamo
    Reilly, Charles S.
    Lambert, David G.
    PLOS ONE, 2013, 8 (09):
  • [29] Activation of the nociceptin/orphanin-FQ receptor promotes NREM sleep and EEG slow wave activity
    Morairty, Stephen R.
    Sun, Yu
    Toll, Lawrence
    Bruchas, Michael R.
    Kilduff, Thomas S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (13)
  • [30] Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats
    Micheli, Laura
    Mannelli, Lorenzo Di Cesare
    Guerrini, Remo
    Trapella, Claudio
    Zanardelli, Matteo
    Ciccocioppo, Roberto
    Rizzi, Anna
    Ghelardini, Carla
    Calo, Girolamo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 754 : 79 - 87
12345